Bank of New York Mellon’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,538,421
| Closed | -$1.36M | – | 4481 |
|
|
2022
Q4 | $1.36M | Buy |
1,538,421
+223,787
| +17% | +$297K | ﹤0.01% | 3045 |
|
|
2022
Q3 | $2.06M | Buy |
1,314,634
+105,495
| +9% | +$239K | ﹤0.01% | 2832 |
|
|
2022
Q2 | $2.43M | Buy |
1,209,139
+223,637
| +23% | +$387K | ﹤0.01% | 2721 |
|
|
2022
Q1 | $2.3M | Buy |
985,502
+27,241
| +3% | +$85K | ﹤0.01% | 2854 |
|
|
2021
Q4 | $4.46M | Sell |
958,261
-204,124
| -18% | -$1.27M | ﹤0.01% | 2525 |
|
|
2021
Q3 | $8.87M | Buy |
1,162,385
+149,208
| +15% | +$1.27M | ﹤0.01% | 2196 |
|
|
2021
Q2 | $9.82M | Buy |
1,013,177
+104,926
| +12% | +$836K | ﹤0.01% | 2145 |
|
|
2021
Q1 | $7.51M | Sell |
908,251
-20,177
| -2% | -$213K | ﹤0.01% | 2252 |
|
|
2020
Q4 | $6.34M | Buy |
928,428
+172,990
| +23% | +$1.39M | ﹤0.01% | 2244 |
|
|
2020
Q3 | $8.42M | Buy |
755,438
+108,734
| +17% | +$995K | ﹤0.01% | 1945 |
|
|
2020
Q2 | $4.06M | Buy |
646,704
+234,607
| +57% | +$898K | ﹤0.01% | 2314 |
|
|
2020
Q1 | $758K | Buy |
412,097
+7,633
| +2% | +$22K | ﹤0.01% | 3157 |
|
|
2019
Q4 | $1.37M | Sell |
404,464
-28,064
| -6% | -$66.9K | ﹤0.01% | 3068 |
|
|
2019
Q3 | $926K | Sell |
432,528
-20,529
| -5% | -$47.8K | ﹤0.01% | 3220 |
|
|
2019
Q2 | $1.21M | Buy |
453,057
+16,906
| +4% | +$60.8K | ﹤0.01% | 3091 |
|
|
2019
Q1 | $2.07M | Buy |
436,151
+13,700
| +3% | +$35.9K | ﹤0.01% | 2757 |
|
|
2018
Q4 | $1.01M | Buy |
422,451
+25,085
| +6% | +$81.9K | ﹤0.01% | 3091 |
|
|
2018
Q3 | $1.75M | Buy |
397,366
+84,947
| +27% | +$471K | ﹤0.01% | 2927 |
|
|
2018
Q2 | $2.25M | Buy |
312,419
+253,360
| +429% | +$1.72M | ﹤0.01% | 2790 |
|
|
2018
Q1 | $305K | Buy |
59,059
+4,461
| +8% | +$31.7K | ﹤0.01% | 3792 |
|
|
2017
Q4 | $207K | Buy |
54,598
+21,064
| +63% | +$54.9K | ﹤0.01% | 3938 |
|
|
2017
Q3 | $57K | Buy |
33,534
+5,646
| +20% | +$10.4K | ﹤0.01% | 4091 |
|
|
2017
Q2 | $56K | Sell |
27,888
-121,536
| -81% | -$237K | ﹤0.01% | 4116 |
|
|
2017
Q1 | $590K | Sell |
149,424
-331
| -0.2% | -$1.66K | ﹤0.01% | 3488 |
|
|
2016
Q4 | $734K | Buy |
149,755
+38,052
| +34% | +$229K | ﹤0.01% | 3427 |
|
|
2016
Q3 | $865K | Sell |
111,703
-6,143
| -5% | -$41.4K | ﹤0.01% | 3252 |
|
|
2016
Q2 | $660K | Sell |
117,846
-45
| -0% | -$288 | ﹤0.01% | 3399 |
|
|
2016
Q1 | $635K | Buy |
117,891
+28,248
| +32% | +$164K | ﹤0.01% | 3320 |
|
|
2015
Q4 | $781K | Sell |
89,643
-3,561
| -4% | -$30K | ﹤0.01% | 3317 |
|
|
2015
Q3 | $782K | Sell |
93,204
-77,519
| -45% | -$1.23M | ﹤0.01% | 3334 |
|
|
2015
Q2 | $3.01M | Buy |
170,723
+149,084
| +689% | +$1.92M | ﹤0.01% | 2656 |
|
|
2015
Q1 | $250K | Buy |
21,639
+6,118
| +39% | +$70.8K | ﹤0.01% | 3837 |
|
|
2014
Q4 | $156K | Buy |
15,521
+3,805
| +32% | +$19.3K | ﹤0.01% | 3955 |
|
|
2014
Q3 | $53K | Hold |
11,716
| – | – | ﹤0.01% | 4140 |
|
|
2014
Q2 | $79K | Buy |
+11,716
| New | +$88.3K | ﹤0.01% | 4025 |
|
Other funds holding SRNE
PP
OCM
OFA
CGA
LCM
STB
GA
HFRG
VFA
GBWM